Butylamine

Butylamine

SCHEMBL3285128

C=C(C)C(=O)OCC.CCCCN

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.56
THRB P10828 1/20 0.48
CYP1A2 P05177 1/20 0.47
ALDH1A1 P00352 6/20 0.41
GLO1 Q04760 1/20 0.38
LMNA P02545 1/20 0.38
HSD17B10 Q99714 1/20 0.38
FAAH O00519 2/20 0.38
CPB2 Q96IY4 1/20 0.38
ALOX15 P16050 1/20 0.37
MGAM O43451 1/20 0.37
GAA P10253 1/20 0.37
SI P14410 1/20 0.37
MGAM2 Q2M2H8 1/20 0.37
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10348982 0.93 TSHR (0.62) TSHRTHRBCYP1A2ALDH1A1FAAH
SCHEMBL9639706 0.93 TSHR (0.62) TSHRTHRBCYP1A2ALDH1A1FAAH
Propylamine SCHEMBL3280862 0.90 THRB (0.53) TSHRTHRBCYP1A2ALDH1A1GLO1
Ethylenediamine SCHEMBL4650024 0.88 THRB (0.61) TSHRTHRBCYP1A2ALDH1A1GLO1
Butylamine SCHEMBL3281168 0.87 TSHR (0.65) TSHRTHRBCYP1A2ALDH1A1MAPT
Decane SCHEMBL27941727 0.86 TSHR (0.74) TSHRTHRBALDH1A1GLO1LMNA
Ethylamine SCHEMBL4364175 0.86 THRB (0.57) TSHRTHRBCYP1A2ALDH1A1GLO1
Hexadecane SCHEMBL28334360 0.84 TSHR (0.71) TSHRTHRBALDH1A1GLO1LMNA
SCHEMBL5576923 0.84 THRB (0.55) TSHRTHRBCYP1A2ALDH1A1GLO1
Hydroxyamine SCHEMBL29435122 0.83 THRB (0.59) TSHRTHRBALDH1A1GLO1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11717471-B2 Hydrogel microcapsules ISP INVESTMENTS LLC (US) 2023-08-08 US claimed
EP-3390483-B1 ENCAPSULATION PROCTER & GAMBLE (US) 2022-05-18 EP claimed
CN-107708853-B Encapsulation 恩盖普有限公司 2021-12-07 CN claimed
EP-3368207-B1 ENCAPSULATION ENCAPSYS LLC (US) 2021-12-01 EP claimed
CN-112585230-A UV curable hot melt adhesive composition for floor application 巴斯夫欧洲公司 2021-03-30 CN claimed
US-10864167-B2 Encapsulation THE PROCTER & GAMBLE COMPANY (US) 2020-12-15 US claimed
EP-3390483-A1 ENCAPSULATION The Procter and Gamble Company (US) 2018-10-24 EP claimed
EP-3368207-A1 ENCAPSULATION ENCAPSYS, LLC (US) 2018-09-05 EP claimed
US-20180235893-A1 ENCAPSULATION THE PROCTER & GAMBLE COMPANY 2018-08-23 US claimed
US-9937477-B2 Encapsulation WATERTITE PRODUCTS, INC. 2018-04-10 US claimed
US-9725589-B2 Method of preparing acrylic polymers and products produced thereby LUBRIZOL ADVANCED MATERIALS, INC. (US) 2017-08-08 US claimed
WO-2017074995-A1 ENCAPSULATION ENCAPSYS, LLC (US) 2017-05-04 WO claimed
WO-2017074997-A1 ENCAPSULATION ENCAPSYS, LLC (US) 2017-05-04 WO claimed
US-20170113200-A1 Encapsulation Encapsys,LLC (US) 2017-04-27 US claimed
US-20140336343-A1 Method Of Preparing Acrylic Polymers And Products Produced Thereby LUBRIZOL ADVANCED MATERIALS, INC. 2014-11-13 US claimed
US-20130302392-A1 HYDROGEL MICROCAPSULES HERCULES LLC 2013-11-14 US claimed
EP-2646002-A2 HYDROGEL MICROCAPSULES Isp Investments Inc. (US) 2013-10-09 EP claimed
WO-2012075293-A2 HYDROGEL MICROCAPSULES ISP INVESTMENTS INC. (US) 2012-06-07 WO claimed
US-20060181587-A1 Ink set and media for ink-jet printing HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. 2006-08-17 US claimed
EP-0340975-B1 ETHYLENE COPOLYMERS AS SORBERS OF METALLIC IONS FROM SOLUTIONS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1992-09-30 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11717471-B2 Hydrogel microcapsules MITF, DSG1, SHH TSHR 2621/4885THRB 3065/4885CYP1A2 2974/4885
US-20180235893-A1 ENCAPSULATION ACR, ACMSD, SAMM50 TSHR 4720/4885THRB 3902/4885CYP1A2 1561/4885
US-10864167-B2 Encapsulation ACR, MPHOSPH6, ACMSD TSHR 4661/4885THRB 3634/4885CYP1A2 1650/4885
US-20130302392-A1 HYDROGEL MICROCAPSULES MITF, DSG1, SHH TSHR 2621/4885THRB 3065/4885CYP1A2 2974/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.